The International Thoroughbred Breeders' Federation (ITBF) has concluded its biennial Conference, this year hosted by the Japan Bloodhorse Breeders' Association (JBBA) over five days.
The 70 ITBF delegates from 21 of the 27 member countries first attended the G1 Yushun Himba (Japanese Oaks) in Tokyo, before being flown to Hokkaido for a two-day tour. An array of world-class stallions were shown at Shadai Stallion Station, Darley Japan and JBBA Shizunai Stallion Station, as well as the exceptional facilities at the JRA's Hikada Training and Research Centre.
The attendees later returned to Tokyo to participate in a half-day Veterinary Meeting and an all-day General Meeting. The plenary veterinary lecture delivered by the host nation educated the audience on the important distinction between gene therapy, gene doping and genetic manipulation–and the future implications of all.
Kirsten Rausing, chair of the ITBF, and Winfried Engelbrecht-Bresges, chair of the International Federation of Horseracing Authorities (IFHA), shared views on Thoroughbred industry enhancement through working collaboratively, while attendees also enjoyed presentations on equine welfare as the foundation of a socially responsible sport, environmental sustainability in stud farming and the impact of racetrack closures in the USA, amongst other topics.
In addition, ITBF members voted unanimously to continue to stand resolute against the use of all artificial breeding methods.
The ITBF, which works to advance and protect the interests of Thoroughbred breeders throughout the world, will hold its next General Meeting when France hosts in 2026.
Not a subscriber? Click here to sign up for the daily PDF or alerts.
